Holen Sie sich die Stockscreener-App
188.15
2.50%
-4.83
Vorhandelsmarkt:
186.03
-2.12
-1.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$192.98
Offen:
$192.74
24-Stunden-Volumen:
1.63M
Relative Volume:
0.60
Marktkapitalisierung:
$53.93B
Einnahmen:
$21.39B
Nettoeinkommen (Verlust:
$1.61B
KGV:
33.84
EPS:
5.56
Netto-Cashflow:
$2.55B
1W Leistung:
-3.05%
1M Leistung:
+6.68%
6M Leistung:
-16.57%
1J Leistung:
-22.38%
1-Tages-Spanne:
$188.03
$193.99
1-Wochen-Bereich:
$188.03
$195.65
52-Wochen-Spanne:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Vergleichen Sie BDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
188.15 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ISRG
Intuitive Surgical Inc
|
469.07 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
|
RMD
Resmed Inc
|
270.99 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.27 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
243.74 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-02 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Infusion Pump Market to Reach USD 23.13 Billion by 2032, Driven by Rising Chronic Disease Burden & Tech Innovation | SNS Insider - GlobeNewswire Inc.
Combining machine learning predictions for Becton Dickinson and CompanyWeekly Gains Summary & Growth Focused Stock Reports - Newser
Becton Dickinson Stock Plunges 2.5% Amid PAD Initiatives Ranked 359th in 310M Trading Volume - AInvest
Why Becton Dickinson and Company is moving todayEarnings Beat & Risk Managed Investment Entry Signals - Newser
Becton, Dickinson & Co Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
What Becton Dickinson (BDX)'s Revenue Miss and Ongoing Buybacks Signal for Shareholder Value - simplywall.st
Using data models to predict Becton Dickinson and Company stock movement2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Will Becton Dickinson and Company benefit from macro trends2025 Geopolitical Influence & Daily Stock Trend Watchlist - Newser
Pattern recognition hints at Becton Dickinson and Company upsideDay Trade & Technical Pattern Based Signals - Newser
SEC Form SC 13G/A filed by Becton Dickinson and Company (Amendment) - Quantisnow
Becton Dickinson and Company stock chart pattern explainedJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Intraday pattern recognizer results for Becton Dickinson and CompanyGlobal Markets & AI Driven Price Predictions - Newser
Bullish Becton Dickinson Insiders Loaded Up On US$1.36m Of Stock - 富途牛牛
SEC Form 425 filed by Becton Dickinson and Company - Quantisnow
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care - Quantisnow
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home - Quantisnow
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - Quantisnow
Regression analysis insights on Becton Dickinson and Company performanceJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - Newser
What MACD signals say about Becton Dickinson and CompanyWatch List & Free Verified High Yield Trade Plans - Newser
Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2 - MSN
Does Becton Dickinson and Company show high probability of reboundWeekly Stock Recap & High Accuracy Buy Signal Tips - Newser
Published on: 2025-08-29 11:35:51 - Newser
Tools to monitor Becton Dickinson and Company recovery probability2025 Big Picture & Weekly High Return Opportunities - Newser
Chart based analysis of Becton Dickinson and Company trends2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
Published on: 2025-08-28 16:05:43 - Newser
Becton Dickinson Options Implied Volatility Surges: What Does it Mean? - AInvest
Are Options Traders Betting on a Big Move in Becton Dickinson Stock? - Yahoo Finance
Breakout Traders Target Becton Dickinson and Company on Recovery Setup getLinesFromResByArray error: size == 0 - classian.co.kr
Here's Why Becton Dickinson (BDX) is a Strong Value Stock - Yahoo Finance
Becton Dickinson Insider Sells Shares Amid Undervalued Stock - AInvest
Becton Dickinson Stock Price, Quotes and Forecasts | NYSE:BDX - Benzinga
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Can trapped investors hope for a rebound in Becton Dickinson and CompanyPortfolio Gains Summary & Growth Focused Entry Point Reports - Newser
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Why Becton Dickinson Shares Are Under Scrutiny - TipRanks
Becton, Dickinson and Company (NYSE:BDX) Stock Unloaded Rep. Lisa C. McClain - Defense World
BD PosiFlush™ SafeScrub Study: A Potential Game-Changer for Medical Device Safety - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson and Company stock trend outlook and recovery pathTrade Volume Report & Real-Time Stock Price Movement Reports - Newser
Is Becton Dickinson and Company stock reversal real or fakeRate Cut & Fast Entry High Yield Tips - Newser
Becton, Dickinson And Company Stock: Is Wall Street Bullish Or Bearish? - Barchart.com
Becton, Dickinson: Great Time To Buy This Dividend Aristocrat (BDX) - Seeking Alpha
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):